While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health
found significant inconsistencies in online peptide vendor quality with many peptides showing less than 80% purity or no active compound at all
If you are getting both injections, they can even be given on the same day (different syringes, possibly different sites)
With injections, the complete vitamin is absorbed into your bloodstream, bypassing the inefficiencies of digestion
Material Safety Data Sheet (MSDS): Comprehensive Safety & Handling Protocol Documentation